Forward Pharma A/S ADR | Ownership
Companies that own Forward Pharma A/S ADR
BVF Partners LP
8,503,425
18.02%
3,748,308
1.8%
06/30/2018
Morgan Stanley & Co. LLC
132,817
0.28%
61,926
0%
06/30/2018
Renaissance Technologies LLC
80,200
0.17%
-49,900
0%
06/30/2018
Apo Asset Management GmbH
56,220
0.12%
40,220
0.01%
06/29/2018
SSgA Funds Management, Inc.
29,406
0.06%
-3,755
0%
06/30/2018
DWS Investment GmbH
19,331
0.04%
-45,112
0%
06/30/2018
Acadian Asset Management LLC
18,599
0.04%
18,599
0%
06/30/2018
Citadel Advisors LLC
11,102
0.02%
11,102
0%
06/30/2018
SEI Investments Management Corp.
7,337
0.02%
7,337
0%
06/30/2018
Perinvest (UK) Ltd.
3,800
0.01%
3,800
0.07%
06/30/2017
| Address |
Østergade 24A
Copenhagen CR 1100
Denmark
|
|
Employees
|
- |
| Website |
http://www.forward-pharma.com |
| Updated |
07/08/2019 |
| Forward Pharma is a biopharmaceutical company, which engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark. |
